<VariationArchive VariationID="410651" VariationName="NM_198253.3(TERT):c.336dup (p.Glu113fs)" VariationType="Duplication" Accession="VCV000410651" Version="32" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2017-04-17" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="394824" VariationID="410651">
      <GeneList>
        <Gene Symbol="TERT" FullName="telomerase reverse transcriptase" GeneID="7015" HGNC_ID="HGNC:11730" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5p15.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="1253167" stop="1295068" display_start="1253167" display_stop="1295068" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="1253281" stop="1295161" display_start="1253281" display_stop="1295161" Strand="-" />
          </Location>
          <OMIM>187270</OMIM>
          <Haploinsufficiency last_evaluated="2011-11-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TERT">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2011-11-17" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TERT">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_198253.3(TERT):c.336dup (p.Glu113fs)</Name>
      <CanonicalSPDI>NC_000005.10:1294549:GGGGGGG:GGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5p15.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="1294549" stop="1294550" display_start="1294549" display_stop="1294550" variantLength="1" positionVCF="1294549" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="1294664" stop="1294665" display_start="1294664" display_stop="1294665" variantLength="1" positionVCF="1294664" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <OtherNameList>
        <Name>p.Glu113fs</Name>
      </OtherNameList>
      <ProteinChange>E113fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.1294556dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.1294556dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.1294671dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.1294671dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009265.1" sequenceAccession="NG_009265" sequenceVersion="1" change="g.5498dup">
            <Expression>NG_009265.1:g.5498dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_055467.1" sequenceAccession="NG_055467" sequenceVersion="1" change="g.29dup">
            <Expression>NG_055467.1:g.29dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001193376.3" sequenceAccession="NM_001193376" sequenceVersion="3" change="c.336dup">
            <Expression>NM_001193376.3:c.336dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001180305.1" sequenceAccession="NP_001180305" sequenceVersion="1" change="p.Glu113fs">
            <Expression>NP_001180305.1:p.Glu113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198253.3" sequenceAccession="NM_198253" sequenceVersion="3" change="c.336dup" MANESelect="true">
            <Expression>NM_198253.3:c.336dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_937983.2" sequenceAccession="NP_937983" sequenceVersion="2" change="p.Glu113fs">
            <Expression>NP_937983.2:p.Glu113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149162.3" sequenceAccession="NR_149162" sequenceVersion="3" change="n.415dup">
            <Expression>NR_149162.3:n.415dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_149163.3" sequenceAccession="NR_149163" sequenceVersion="3" change="n.415dup">
            <Expression>NR_149163.3:n.415dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_343" sequenceAccession="LRG_343">
            <Expression>LRG_343:g.5498dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198253.2" sequenceAccession="NM_198253" sequenceVersion="2" change="c.336dupC">
            <Expression>NM_198253.2:c.336dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198253.3" sequenceAccession="NM_198253" sequenceVersion="3" change="c.336dupC" MANESelect="true">
            <Expression>NM_198253.3:c.336dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1060502990" DB="dbSNP" />
        <XRef ID="CA16611799" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198253.3(TERT):c.336dup (p.Glu113fs) AND multiple conditions" Accession="RCV002481460" Version="8">
        <ClassifiedConditionList TraitSetID="46946">
          <ClassifiedCondition DB="MedGen" ID="C0023467">Acute myeloid leukemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0002874">Aplastic anemia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551974">Dyskeratosis congenita, autosomal dominant 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151443">Dyskeratosis congenita, autosomal dominant 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C5561926">Interstitial lung disease 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3554574">Melanoma, cutaneous malignant, susceptibility to, 9</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3553617">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-11" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198253.3(TERT):c.336dup (p.Glu113fs) AND Pulmonary fibrosis" Accession="RCV002509393" Version="8">
        <ClassifiedConditionList TraitSetID="20722">
          <ClassifiedCondition DB="MedGen" ID="C0034069">Pulmonary fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-06-09" SubmissionCount="1">Likely risk allele</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_198253.3(TERT):c.336dup (p.Glu113fs) AND multiple conditions" Accession="RCV002525584" Version="9">
        <ClassifiedConditionList TraitSetID="82309">
          <ClassifiedCondition DB="MedGen" ID="C3151443">Dyskeratosis congenita, autosomal dominant 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1800706">Idiopathic Pulmonary Fibrosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-28" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-04-17" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16247010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17460043</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31268371</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-31">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="20722" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="22926" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis</ElementValue>
                <XRef ID="HP:0002206" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0002771" DB="MONDO" />
              </Name>
              <XRef ID="C0034069" DB="MedGen" />
              <XRef ID="MONDO:0002771" DB="MONDO" />
              <XRef Type="primary" ID="HP:0002206" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006523" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="82309" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66626" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Idiopathic Pulmonary Fibrosis</ElementValue>
                <XRef ID="700250006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Idiopathic fibrosing alveolitis, chronic form</ElementValue>
              </Name>
              <XRef ID="C1800706" DB="MedGen" />
              <XRef ID="D054990" DB="MeSH" />
            </Trait>
            <Trait ID="16124" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 2</ElementValue>
                <XRef ID="MONDO:0013521" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA2</ElementValue>
                <XRef Type="MIM" ID="613989" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15741" />
                <XRef ID="15741" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3151443" DB="MedGen" />
              <XRef ID="MONDO:0013521" DB="MONDO" />
              <XRef Type="MIM" ID="613989" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="46946" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4974" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 1</ElementValue>
                <XRef ID="MONDO:0007485" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dyskeratosis congenita autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dyskeratosis congenita Scoggins type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DKCA1</ElementValue>
                <XRef Type="MIM" ID="127550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6299" />
                <XRef ID="6299" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Variable</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21610750</ID>
              </Citation>
              <XRef ID="1775" DB="Orphanet" />
              <XRef ID="C4551974" DB="MedGen" />
              <XRef ID="MONDO:0007485" DB="MONDO" />
              <XRef Type="MIM" ID="127550" DB="OMIM" />
            </Trait>
            <Trait ID="4604" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aplastic anemia</ElementValue>
                <XRef ID="Aplastic+Anemia/556" DB="Genetic Alliance" />
                <XRef ID="HP:0001915" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0015909" DB="MONDO" />
                <XRef ID="306058006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20234" />
                <XRef ID="20234" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="182040" DB="Orphanet" />
              <XRef ID="88" DB="Orphanet" />
              <XRef ID="C0002874" DB="MedGen" />
              <XRef ID="MONDO:0015909" DB="MONDO" />
              <XRef Type="MIM" ID="609135" DB="OMIM" />
              <XRef Type="primary" ID="HP:0001915" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="16124" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 2</ElementValue>
                <XRef ID="MONDO:0013521" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DKCA2</ElementValue>
                <XRef Type="MIM" ID="613989" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15741" />
                <XRef ID="15741" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3151443" DB="MedGen" />
              <XRef ID="MONDO:0013521" DB="MONDO" />
              <XRef Type="MIM" ID="613989" DB="OMIM" />
            </Trait>
            <Trait ID="17693" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Cutaneous malignant melanoma 9</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Melanoma, cutaneous malignant, susceptibility to, 9</ElementValue>
                <XRef ID="MONDO:0014056" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMM9</ElementValue>
                <XRef Type="MIM" ID="615134" DB="OMIM" />
              </Symbol>
              <XRef ID="618" DB="Orphanet" />
              <XRef ID="C3554574" DB="MedGen" />
              <XRef ID="MONDO:0014056" DB="MONDO" />
              <XRef Type="MIM" ID="615134" DB="OMIM" />
            </Trait>
            <Trait ID="4065" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Interstitial lung disease 2</ElementValue>
                <XRef ID="MONDO:0800029" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fibrosing alveolitis, cryptogenic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial idiopathic pulmonary fibrosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fibrocystic pulmonary dysplasia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ILD2</ElementValue>
                <XRef Type="MIM" ID="178500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">UIP</ElementValue>
                <XRef Type="MIM" ID="178500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SFTPC-Related Familial Pulmonary Fibrosis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8609" />
                <XRef ID="8609" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <XRef ID="2032" DB="Orphanet" />
              <XRef ID="79126" DB="Orphanet" />
              <XRef ID="C5561926" DB="MedGen" />
              <XRef ID="MONDO:0800029" DB="MONDO" />
              <XRef Type="MIM" ID="178500" DB="OMIM" />
            </Trait>
            <Trait ID="15736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Acute myeloid leukemia, adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AML adult</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute myelogenous leukemia</ElementValue>
                <XRef ID="Acute+Myeloid+Leukemia%2C+Adult/204" DB="Genetic Alliance" />
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute non-lymphocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acute granulocytic leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myeloid, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukemia, acute myelogenous, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acute myeloid leukemia</ElementValue>
                <XRef ID="HP:0004808" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0018874" DB="MONDO" />
                <XRef ID="519" DB="Orphanet" />
                <XRef ID="17788007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AML</ElementValue>
                <XRef ID="GTR000500636" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="601626" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12757" />
                <XRef ID="12757" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">Constitutively activated FLT3</Attribute>
                <XRef ID="GTR000552464" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification)</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20963938</ID>
                <ID Source="BookShelf">NBK47457</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2013">
                <ID Source="PubMed">23970018</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33226740</ID>
                <ID Source="BookShelf">NBK564234</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34723452</ID>
                <ID Source="BookShelf">NBK574843</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2020">
                <ID Source="PubMed">32171751</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/all.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Lymphoblastic Leukemia, 2024</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Acute Myeloid Leukemia, 2023</CitationText>
              </Citation>
              <XRef ID="519" DB="Orphanet" />
              <XRef ID="C0023467" DB="MedGen" />
              <XRef ID="D015470" DB="MeSH" />
              <XRef ID="MONDO:0018874" DB="MONDO" />
              <XRef Type="MIM" ID="601626" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004808" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001914" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004843" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005516" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006724" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0006728" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="17340" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1</ElementValue>
                <XRef ID="MONDO:0013878" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 1</ElementValue>
                <XRef Type="MIM" ID="614742" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0021" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="187270.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFBMFT1</ElementValue>
                <XRef Type="MIM" ID="614742" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="88" DB="Orphanet" />
              <XRef ID="C3553617" DB="MedGen" />
              <XRef ID="MONDO:0013878" DB="MONDO" />
              <XRef Type="MIM" ID="614742" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4986670" SubmissionDate="2022-07-12" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="5-1294664-C-CG|Pulmonary fibrosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002547347" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="Garcia Pulmonary Genetics Research Laboratory, Columbia University Irving Medical Center" OrgID="508570" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely risk allele</GermlineClassification>
          <Comment>Leukocyte telomere length (by qPCR) less than 10th percentile age-adjusted</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TERT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Glu113fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198253.3:c.336dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Pulmonary fibrosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11782274</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5432848" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_198253.3:c.336dup|OMIM:127550;178500;601626;609135;613989;614742;615134" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002777968" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_198253.3:c.336dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="127550" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="178500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601626" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609135" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613989" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614742" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615134" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1064391" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2017-04-17">
        <ClinVarSubmissionID localKey="1088441|MedGen:C3151443;C1800706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000551487" DateUpdated="2024-02-28" DateCreated="2017-04-17" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16247010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17460043</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31268371</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu113Argfs*79) in the TERT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TERT are known to be pathogenic (PMID: 16247010, 17460043). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with chronic hypersensitivity pneumonitis (PMID: 31268371). ClinVar contains an entry for this variant (Variation ID: 410651). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TERT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.1294664_1294665insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151443" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1800706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2017March_Invitae</SubmissionName>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="609135" MappingRef="OMIM">
        <MedGen CUI="C0002874" Name="Aplastic anemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="178500" MappingRef="OMIM">
        <MedGen CUI="C5561926" Name="Interstitial lung disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="613989" MappingRef="OMIM">
        <MedGen CUI="C3151443" Name="Dyskeratosis congenita, autosomal dominant 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1064391" TraitType="Disease" MappingType="XRef" MappingValue="C3151443" MappingRef="MedGen">
        <MedGen CUI="C3151443" Name="Dyskeratosis congenita, autosomal dominant 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="127550" MappingRef="OMIM">
        <MedGen CUI="C4551974" Name="Dyskeratosis congenita, autosomal dominant 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="614742" MappingRef="OMIM">
        <MedGen CUI="C3553617" Name="Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1064391" TraitType="Disease" MappingType="XRef" MappingValue="C1800706" MappingRef="MedGen">
        <MedGen CUI="C1800706" Name="Idiopathic Pulmonary Fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="615134" MappingRef="OMIM">
        <MedGen CUI="C3554574" Name="Melanoma, cutaneous malignant, susceptibility to, 9" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4986670" TraitType="Finding" MappingType="Name" MappingValue="Pulmonary fibrosis" MappingRef="Preferred">
        <MedGen CUI="C0034069" Name="Pulmonary fibrosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5432848" TraitType="Disease" MappingType="XRef" MappingValue="601626" MappingRef="OMIM">
        <MedGen CUI="C0023467" Name="Acute myeloid leukemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

